Ophthalmology billing is complex because it runs on two coding systems at once (Eye codes and E/M codes), stacks a 92-day global surgical period on top of one of Medicare’s highest-volume procedures, and demands drug-level accuracy for injectable medications that cost more per dose than a typical office visit.
A federal watchdog just flagged $124 million in questionable same-day claims tied to this exact mix. This isn’t a “bill it and move on” specialty, and treating it like one is why so many practices leave revenue on the table.
If you run finance or operations for an ophthalmology practice, ASC, or multi-provider eye group, you already feel this. Volume is strong, yet the aging report still doesn’t shrink the way it should. The reason usually isn’t your clinical team. It’s structural.
Why Is Ophthalmology Billing So Complicated?
Most specialties bill against one coding system. Ophthalmology runs two in parallel, and your coders make that call daily. Eye exam codes (92002-92014) exist specifically for ophthalmologic evaluation, separate from the standard E/M codes (99202-99215) every other specialty uses, with different documentation requirements and different reimbursement. Pick the wrong family and you get a denial, or an overpayment finding months later.
Layer on a surgical specialty where cataract extraction remains one of Medicare’s most frequently performed procedures, and where nearly every major eye surgery carries a global period. CMS’s Global Surgery Booklet confirms the window runs 92 days total: one day of pre-op care, the surgery date, and 90 days of post-op follow-up, all bundled into a single payment. A separately billed post-op visit inside that window, even an honest mistake, denies automatically.
Five Reasons Ophthalmology Billing Puts Your Margins at Risk
1. Same-Day E/M and Injection Modifier Risk.
This is the piece most practices underestimate, and it’s now under direct federal scrutiny. An HHS Office of Inspector General audit found Medicare paid $124 million for 1.4 million E/M services billed the same day as eye injections over a 12-month period.
Providers billed an E/M service alongside 42 percent of all intravitreal injections reviewed, and documentation failed to support modifier 25 use in 22 of 24 sampled claims, a 92 percent failure rate (HHS OIG, Report A-09-23-03014, issued May 27, 2025). OIG has recommended CMS recover up to $123.9 million by December 2026.
2. Global Period Bundling on High-Dollar Surgical Cases.
Any post-op visit, complication follow-up, or unrelated same-week claim that isn’t coded with the correct modifier gets absorbed into the original payment or denied outright. Practices that don’t track each patient’s individual 92-day window on a calendar, not by memory, lose reimbursement they’re legitimately owed.
3. Drug Acquisition and Prior Authorization Complexity.
Anti-VEGF injections for wet macular degeneration and diabetic retinopathy run through a buy-and-bill model: your practice purchases the drug, administers it, and bills the injection and the drug separately under an exact J-code, NDC number, and waste (JW modifier) documentation. Many Medicare Advantage and commercial plans now require prior authorization on every repeat injection, not just the first. One mismatch and the entire claim can deny.
4. Mutually Exclusive Cataract Codes and Laterality Rules.
Medicare’s own billing and coding guidance for cataract surgery states that cataract removal codes (66830-66984) are mutually exclusive of each other, so only one can be billed per eye regardless of technique (CMS Medicare Coverage Database, Billing and Coding: Cataract Surgery, Article A59805, revised November 14, 2024).
Every claim also needs the correct laterality modifier (-LT, -RT, or -50 for bilateral cases) plus the right postoperative modifier (-78 for a related return to the OR, -79 for an unrelated one). One wrong modifier on a routine bilateral case is enough to trigger a denial.
5. Refraction Is a Statutory Exclusion, Not a Coding Choice.
Medicare excludes eye exams performed to determine refractive error from coverage entirely, regardless of medical necessity, under federal regulation (42 CFR § 411.15(c)). Refraction (CPT 92015) is patient responsibility by law, and it can’t be folded into the same claim as a covered medical eye exam.
Practices that don’t separate the two consistently either under-collect on a service Medicare will never pay, or blur the line enough to invite a documentation review on the covered part of the visit.
What the Latest CMS Fee Schedule Means for Your Margins
CMS finalized two CY2026 conversion factors: $33.40 for clinicians outside Advanced Alternative Payment Models, up 3.26 percent from CY2025’s $32.35, and $33.57 for Qualifying APM Participants. That’s a modest per-claim gain, and it won’t offset revenue lost to the documentation issues above, none of which have anything to do with the fee schedule itself.
Eye Codes vs. E/M Codes at a Glance
| Coding Element | What It Covers | Where Practices Get Tripped Up |
| Eye codes (92002-92014) | Ophthalmologic exam and diagnosis | Used interchangeably with E/M codes without matching documentation |
| E/M codes (99202-99215) | General evaluation and management | Billed same-day with injections without modifier 25 support |
| Global surgery modifiers | Post-op visits inside the 92-day window | Missing or incorrect modifier on legitimately separate services |
| J-codes for anti-VEGF drugs | Drug acquisition billing | NDC mismatch, incorrect waste reporting, missing prior auth |
Generic RCM vs. In-House Billing vs. MBC’s Approach
| Revenue Challenge | Generic RCM Vendor | In-House Team | MBC’s Approach |
| Eye code vs. E/M selection | Applied inconsistently | Depends on individual coder experience | Specialty-trained coders applying payer-specific rules |
| Modifier 25 on injection days | Rarely audited before submission | Reviewed reactively, after denial | Checked against OIG-flagged risk criteria before billing |
| Global period tracking | Manual, if tracked at all | Spreadsheet-based, inconsistent | Automated 92-day tracking per patient, per procedure |
| Drug billing (NDC, waste, prior auth) | Delegated back to the practice | Handled by clinical staff, not billing specialists | Dedicated buy-and-bill and prior authorization workflow |
| Typical Net Collection Ratio | 82%-87% | 84%-89% | 94%-97% |
A Quick Self-Check for Your Practice
Ask your team these five questions, in order:
- Do we bill an E/M code alongside injections more than occasionally? Check whether documentation actually supports modifier 25.
- Do we track each patient’s 92-day global period on a calendar, not from memory?
- Are NDC numbers and waste amounts documented at the time of injection, not reconstructed later?
- Do we double-check laterality and postoperative modifiers on every cataract claim?
- Is refraction always billed and collected separately from the covered eye exam?
Two or more “no” answers means recoverable revenue is likely sitting on your aging report right now.
How MBC Handles This Differently
At Medical Billers and Coders, our ophthalmology billing services aren’t an add-on to a general medical billing and coding services package. Our specialty-trained coders handle correct eye code versus E/M selection, 92-day global period tracking, cataract code and modifier accuracy, refraction separation, and a dedicated buy-and-bill workflow for anti-VEGF injectables, including NDC accuracy and prior authorization follow-up.
This sits inside a revenue cycle management approach built for high-complexity specialties. Practices comparing options can review our state-wise medical billing services across every U.S. market and our transparent, outcome-based pricing model to see how our RCM services scale with claim volume.
Summary
Ophthalmology billing is complex for structural reasons: two parallel coding systems, a 92-day global surgical period on some of Medicare’s highest-volume procedures, drug-level accuracy requirements most generic billing vendors aren’t built for, strict cataract code and modifier rules, and a statutory refraction exclusion that has to be billed separately every time.
A federal audit has already flagged $124 million in same-day E/M and injection billing for recovery. None of this is unmanageable. It just needs a team that treats eye codes, global periods, drug billing, and refraction as the specialty-specific disciplines they are, not line items on a generic aging report.
Get Your Billing Reviewed Before It Becomes an Audit Finding
Request a complimentary billing audit from Medical Billers and Coders and get a claim-level look at your modifier 25 usage and global period tracking before a payer flags it for you.
Call us at 888-357-3226 or email info@medicalbillersandcoders.com to schedule your review this week.
FAQs: Ophthalmology Billing
It runs its own Eye exam code set (92002-92014) alongside standard E/M codes (99202-99215), and picking the wrong one is one of the most common causes of denials and post-payment review.
Only when documentation clearly supports a separately identifiable service under modifier 25. A recent federal audit found this unsupported in 92 percent of sampled claims, so same-day billing needs strong, specific documentation, not routine use.
Most eye surgeries carry a 92-day global period covering one day pre-op, the surgery date, and 90 days post-op. Services inside that window are already paid for unless they qualify as a genuinely separate, correctly modified claim.
They require an exact NDC number, correct waste (JW modifier) reporting, and often prior authorization on every repeat injection. A mismatch on any one element can deny the entire claim.
General billing vendors aren’t typically built around dual coding systems, global surgical periods, or drug-level buy-and-bill accuracy. This specialty needs coders trained specifically in those mechanics.
Sources:
- Global Surgery Booklet, MLN907166 — CMS.gov, revised December 2025
- Medicare Payments for Evaluation and Management Services Provided on the Same Day as Eye Injections Were at Risk for Noncompliance with Medicare Requirements
- Calendar Year (CY) 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F)
- 42 CFR § 411.15(c), Particular Services Excluded from Coverage — eCFR, current

A Subject Matter Expert in healthcare billing operations with nearly 10 years of experience, sharing insights on claims processing, coding support, and revenue cycle optimization. Dedicated to educating healthcare professionals on compliance, accuracy, and strategies to improve billing performance.